Furthermore, among the 37 cases of AFP negative sera (37%), 23 cases (62%) were VASN positive (≥ 1.5061ng/ml) (Fig. 2c), which suggested that combining the use of AFP and VASN could improve the sensitivity of liver cancer diagnosis. The gene discussed is VASN; the disease is liver cancer.